The stock market is buzzing with action. If you’re confused about which stocks to keep an eye on, here is a comprehensive overview of all the stock-related news that made headlines. You can keep a hawk-eye on these stocks today, March 11.
Stocks in Focus: From Vodafone Idea to Adani Energy Solutions, you can read about all the stocks that may see action. Previously, on Monday, the NSE Nifty 50 closed the session 92 points or 0.41% lower at 22,460, while the BSE Sensex fell 217 points or 0.29% to close at 74,115.
Stocks to watch on March 11, 2025
Godrej Consumer Products
Godrej Consumer Products started operations at its first integrated greenfield manufacturing plant in Tamil Nadu. It has an investment of Rs 515 crore. The company aims to develop the unit into an export hub. It will target markets like the US, Latin America (LatAm), and Africa, among others.
IndusInd Bank
IndusInd Bank, the country’s fifth-largest private lender, said on Monday that an internal review of its derivative portfolio revealed discrepancies, which could hit its net worth by approximately 2.35% as of December 2024. With its net worth at Rs 65,102 crore as of December 31, the impact is likely to be around Rs 1,530 crore – more than Rs 1,401.3-crore net profit in the third quarter of the current financial year.
ALSO READAccount discrepancy to hit net worth: IndusInd Bank Vodafone Idea
Vodafone Idea has missed the deadline for submitting a bank guarantee worth Rs 6,091 crore towards the shortfall in its 2015 spectrum auction dues, reported The Financial Express citing sources. The department of telecommunications (DoT) had directed the company to either furnish the bank guarantee or make a cash payment of Rs 5,493 crore by March 10.
ALSO READVodafone Idea misses date to submit Rs 6,091 crore bank guarantee Syngene International
Syngene International, an arm of Biocon, acquired its first biologics facility in the US from Emergent Manufacturing Operations Baltimore, a subsidiary of Emergent BioSolutions. The facility is equipped with multiple monoclonal antibody (mAbs) manufacturing lines. Syngene paid $36.5 million to acquire the company.
Sun Pharmaceutical
Sun Pharmaceutical Industries on Monday announced a definitive agreement to acquire Checkpoint Therapeutics for an upfront cash payment of $355 million (around Rs 3,099.51 crore).
» Read More
